E
The startup develops a platform for the isolation and characterization of extracellular vesicles, specifically exosomes, to enhance regenerative therapies. By forming strategic partnerships with pharmaceutical companies, it enables the integration of exosomes into targeted treatments, improving therapeutic efficacy and versatility in addressing challenges within the pharmaceutical industry.
- Biotechnology
Updated 4 months ago
Funding
$2.4M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a platform for the isolation and characterization of extracellular vesicles, specifically exosomes, to enhance regenerative therapies. By forming strategic partnerships with pharmaceutical companies, it enables the integration of exosomes into targeted treatments, improving therapeutic efficacy and versatility in addressing challenges within the pharmaceutical industry.